Medical, Scientific, and Regulatory Updates
MIKS curates reliable and high-quality information published in the field of regenerative medicine, ensuring you can effortlessly stay current.
Certain news pieces are exclusively available to members. If you wish for unrestricted access to all news articles, you can achieve that by becoming a member of our community. Join as a member today to enjoy complete access to all our content.
-
CLINICAL RESEARCH
International Consensus of GRIIP on the use of PRP in patients with infectious, oncological, and hematological comorbidities
This article summarizes the GRIIP recommendations on PRP in patients with infectious diseases, cancer, or hematological disorders, addressing both efficacy and safety considerations.
October 30, 2025
-
MIKS NEWS
Dr. Mikel Sánchez, once again among the top 2% of the world’s most influential scientists
This international recognition highlights the scientific excellence and high-impact output of the R&D research team at Hospital MiKS.
October 07, 2025
-
CLINICAL RESEARCH
Advances in the treatment of knee osteoarthritis: evidence on the safety and efficacy of allogeneic PRP
A pioneering study by MiKS Hospital shows that allogeneic PRP, derived from responsive donors, reduces pain and improves joint function in patients who did not respond to autologous PRP, without serious adverse effects.
August 13, 2025
-
MIKS NEWS
MiKS Hospital: The new headquarters driving translational science, medical innovation, and advanced training
MiKS Hospital, the new headquarters of MiKS Community to drive translational science, advanced training, and medical innovation.
July 08, 2025
-
MIKS NEWS
The UCA analyzes the impact of extreme fatigue on the plasma of triathletes
The aim is to generate scientific evidence to optimize recovery times and prevent injuries resulting from overtraining in highly demanding sports.
June 10, 2025
-
BASIC RESEARCH
Bioactivity of PRP after prolonged cryopreservation: results of an experimental study
A recent study demonstrates that Platelet Rich Plasma (PRP) maintains its bioactivity after 6 and 12 months of freezing at -20 °C and -80 °C, supporting its deferred clinical use and medical biobanking.
June 04, 2025
-
CLINICAL RESEARCH
Genetics, sex and the use of platelet-rich plasma influence the development of arthrofibrosis after anterior cruciate ligament reconstruction
This study reveals how sex, the use of PRP, and genetic variants influence the risk of developing arthrofibrosis after anterior cruciate ligament reconstruction. It includes a predictive model to identify high-risk patients and improve surgical outcomes.
May 28, 2025
-
MIKS NEWS
MiKS Congress urges scientific community to coordinate efforts on Biological Therapies
More than 40 international experts met in Vitoria-Gasteiz on the occasion of the I MiKS Congress, with the aim of strengthening scientific consensus and highlighting the potential of biological therapies in the field of regenerative medicine. During the meeting, key advances in areas such as cellular aging, chronic inflammation and tissue regeneration were addressed.
April 09, 2025
-
MIKS NEWS
The 1st International MiKS Congress will bring the latest in Biological Therapies to Vitoria – Gasteiz (Spain)
From April 3 to 5, 2025, Vitoria-Gasteiz will be the meeting point for the main international references in biological therapies. This congress will bring together experts in orthopedic surgery, sports medicine and pain management, among others, to explore the latest advances in blood derivatives and cell therapies.
January 06, 2025
-
BASIC RESEARCH
Effects of intramuscular administration of Platelet-Rich Plasma on denervated muscle after peripheral nerve injury
Peripheral nerve injuries (PNI) are common, with more than one million cases annually worldwide, resulting in loss of motor and sensory function and muscle atrophy due to prolonged denervation.
December 27, 2024
-
MIKS NEWS
New developments in platelet-rich plasma (PRP): new advances in the integration of extraplatelet molecules to improve its therapeutic efficacy.
This development represents a crucial step towards more effective and personalized treatments in the field of tissue regeneration.
December 16, 2024
-
BASIC RESEARCH
Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies
Biological therapies are booming and more of these formulations are coming to the market as well as novel systems for the production of PRPs.
September 02, 2024